{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:13:59Z","timestamp":1791400439183,"version":"4.3.3"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.tins.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T23:47:29Z","timestamp":1420588049000},"page":"167-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["The human histaminergic system in neuropsychiatric disorders"],"prefix":"10.1016","volume":"38","author":[{"given":"Ling","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Min","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick F.","family":"Swaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2014.12.008_bib0005","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tins.2014.12.008_bib0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrn3526","article-title":"The histaminergic network in the brain: basic organization and role in disease","volume":"14","author":"Panula","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tins.2014.01.001","article-title":"Developmental roles of brain histamine","volume":"37","author":"Panula","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0020","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","article-title":"L-histidine decarboxylase and Tourette's syndrome","volume":"362","author":"Ercan-Sencicek","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2014.12.008_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2013.10.052","article-title":"Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice","volume":"81","author":"Castellan Baldan","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2014.12.008_bib0030","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ana.23968","article-title":"Greatly increased numbers of histamine cells in human narcolepsy with cataplexy","volume":"74","author":"John","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.24019","article-title":"Increase of histaminergic tuberomammillary neurons in narcolepsy","volume":"74","author":"Valko","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tips.2011.01.003","article-title":"Histamine receptors in the CNS as targets for therapeutic intervention","volume":"32","author":"Passani","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tins.2014.12.008_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.110.166876","article-title":"Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease","volume":"336","author":"Brioni","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2014.12.008_bib0050","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2011.12.026","article-title":"Alterations in the histaminergic system in Alzheimer's disease: a postmortem study","volume":"33","author":"Shan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2014.12.008_bib0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0306-4522(91)90070-5","article-title":"Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains","volume":"44","author":"Airaksinen","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/exnr.2000.7362","article-title":"An altered histaminergic innervation of the substantia nigra in Parkinson's disease","volume":"163","author":"Anichtchik","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0306-4522(90)90307-P","article-title":"A histamine-containing neuronal system in human brain","volume":"34","author":"Panula","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0070","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1046\/j.1460-9568.2002.01951.x","article-title":"The histaminergic system in human thalamus: correlation of innervation to receptor expression","volume":"15","author":"Jin","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0075","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1002\/cne.22480","article-title":"Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus","volume":"518","author":"Krolewski","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/tcr.10036","article-title":"L-histidine decarboxylase as a probe in studies on histamine","volume":"2","author":"Watanabe","year":"2002","journal-title":"Chem. Rec."},{"key":"10.1016\/j.tins.2014.12.008_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-8993(02)02546-5","article-title":"Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus","volume":"939","author":"Trottier","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0304-3940(87)90325-9","article-title":"Hypothalamic pathology in Alzheimer's disease","volume":"74","author":"Saper","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0306-4522(91)90069-Z","article-title":"The histochemical demonstration of monoamine oxidase-containing neurons in the human hypothalamus","volume":"44","author":"Nakamura","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#","article-title":"Human cocaine- and amphetamine-regulated transcript (CART) mRNA is highly expressed in limbic- and sensory-related brain regions","volume":"425","author":"Hurd","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0105","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/cne.22666","article-title":"Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age, and gender identity","volume":"519","author":"Garcia-Falgueras","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0110","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1523\/JNEUROSCI.2341-06.2006","article-title":"Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse","volume":"26","author":"Takahashi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0306-4522(02)00158-6","article-title":"Extracellular histamine levels in the feline preoptic\/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study","volume":"113","author":"Strecker","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01967291","article-title":"Diurnal fluctuation in levels of histamine metabolites in cerebrospinal fluid of rhesus monkey","volume":"26","author":"Prell","year":"1989","journal-title":"Agents Actions"},{"key":"10.1016\/j.tins.2014.12.008_bib0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ymeth.2010.07.004","article-title":"A quantitative in situ hybridization protocol for formalin-fixed paraffin-embedded archival post-mortem human brain tissue","volume":"52","author":"Liu","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.tins.2014.12.008_bib0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5665\/sleep.1838","article-title":"Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases","volume":"35","author":"Shan","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.tins.2014.12.008_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2869.2011.00957.x","article-title":"Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey","volume":"21","author":"Zeitzer","year":"2012","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/074873049300800402","article-title":"Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans","volume":"8","author":"Hofman","year":"1993","journal-title":"J. Biol. Rhythms"},{"key":"10.1016\/j.tins.2014.12.008_bib0145","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1073\/pnas.1305814110","article-title":"Circadian patterns of gene expression in the human brain and disruption in major depressive disorder","volume":"110","author":"Li","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2014.12.008_bib0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pbb.2008.03.010","article-title":"Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist","volume":"90","author":"Liu","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tins.2014.12.008_bib0160","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuropharm.2007.08.014","article-title":"Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"53","author":"Liu","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2014.12.008_bib0165","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1471-4159.2002.00871.x","article-title":"Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy","volume":"81","author":"Rinne","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2014.12.008_bib0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.neurobiolaging.2011.01.004","article-title":"Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus","volume":"33","author":"Shan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2014.12.008_bib0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","article-title":"Pattern of brain destruction in Parkinson's and Alzheimer's diseases","volume":"103","author":"Braak","year":"1996","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.tins.2014.12.008_bib0180","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.46.6.1693","article-title":"Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy","volume":"46","author":"Nakamura","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2014.12.008_bib0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(83)91613-6","article-title":"Brain histidine decarboxylase activity in Parkinson's disease","volume":"1","author":"Garbarg","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2014.12.008_bib0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02260886","article-title":"Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice","volume":"3","author":"Prell","year":"1991","journal-title":"J. Neural. Transm. Park Dis. Dement. Sect."},{"key":"10.1016\/j.tins.2014.12.008_bib0195","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/nbdi.2001.0413","article-title":"Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease","volume":"8","author":"Anichtchik","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2014.12.008_bib0200","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.neurobiolaging.2011.12.026","article-title":"Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study","volume":"33","author":"Shan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2014.12.008_bib0205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1471-4159.2000.0750540.x","article-title":"Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra","volume":"75","author":"Vizuete","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2014.12.008_bib0210","first-page":"114","article-title":"Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans","volume":"2","author":"Prell","year":"1988","journal-title":"Comp. Gerontol. A"},{"key":"10.1016\/j.tins.2014.12.008_bib0215","first-page":"353","article-title":"Brain histamine in Alzheimer's disease","volume":"11","author":"Cacabelos","year":"1989","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0166-4328(01)00215-7","article-title":"Histamine function in brain disorders","volume":"124","author":"Fernandez-Novoa","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1139\/y89-013","article-title":"Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients","volume":"67","author":"Mazurkiewicz-Kwilecki","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0230","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0306-4522(97)00353-9","article-title":"Neuronal histamine deficit in Alzheimer's disease","volume":"82","author":"Panula","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0304-3940(93)90019-H","article-title":"Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease","volume":"151","author":"Nakamura","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0240","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-2010-100381","article-title":"CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease","volume":"22","author":"Motawaj","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2014.12.008_bib0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2012.02.027","article-title":"Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2014.12.008_bib0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1476-5381.2008.00075.x","article-title":"Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice","volume":"157","author":"Medhurst","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0255","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tins.2014.12.008_bib0260","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nlm.2010.10.008","article-title":"Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease","volume":"95","author":"Bardgett","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.tins.2014.12.008_bib0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2010.10.026","article-title":"In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease","volume":"60","author":"Bitner","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2014.12.008_bib0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/156720512800492530","article-title":"Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD","volume":"9","author":"Egan","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0275","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-140291","article-title":"A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia","volume":"42","author":"Haig","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2014.12.008_bib0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205010666131212110148","article-title":"A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease","volume":"11","author":"Grove","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0285","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","article-title":"Hypocretin and melanin-concentrating hormone in patients with Huntington disease","volume":"18","author":"Aziz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2014.12.008_bib0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/syn.890150306","article-title":"Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models","volume":"15","author":"Martinez-Mir","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.tins.2014.12.008_bib0295","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1460-9568.1999.00453.x","article-title":"Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases","volume":"11","author":"Goodchild","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410180207","article-title":"Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes","volume":"18","author":"Whitehouse","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1750-3639.2010.00465.x","article-title":"Functional increase of brain histaminergic signaling in Huntington's disease","volume":"21","author":"van Wamelen","year":"2011","journal-title":"Brain Pathol."},{"issue":"Suppl.","key":"10.1016\/j.tins.2014.12.008_bib0310","first-page":"343","article-title":"Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid","volume":"33","author":"Prell","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.tins.2014.12.008_bib0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2014.12.008_bib0320","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0325","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.02.006","article-title":"Paradoxical function of orexin\/hypocretin circuits in a mouse model of Huntington's disease","volume":"42","author":"Williams","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2014.12.008_bib0330","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/mp.2008.38","article-title":"Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances","volume":"13","author":"Wang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2014.12.008_bib0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0083-6729(10)82018-7","article-title":"Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus","volume":"82","author":"Bao","year":"2010","journal-title":"Vitam Horm"},{"key":"10.1016\/j.tins.2014.12.008_bib0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000054402","article-title":"Stress-induced release of anterior pituitary hormones: effect of H3 receptor-mediated inhibition of histaminergic activity or posterior hypothalamic lesion","volume":"69","author":"Knigge","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tins.2014.12.008_bib0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0753-3322(00)80069-4","article-title":"The role of brain histamine in acute and chronic stresses","volume":"54","author":"Ito","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tins.2014.12.008_bib0350","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/0024-3205(86)90641-7","article-title":"Brain histamine response to stress in 12 month old rats","volume":"38","author":"Mazurkiewicz-Kwilecki","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.tins.2014.12.008_bib0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0091-3057(80)90412-8","article-title":"Single and repeated air blast stress and brain histamine","volume":"12","author":"Mazurkiewicz-Kwilecki","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tins.2014.12.008_bib0360","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.172.3987.1037","article-title":"Brain histamine: rapid apparent turnover altered by restraint and cold stress","volume":"172","author":"Taylor","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.tins.2014.12.008_bib0365","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(99)00052-X","article-title":"Effects of the acute and chronic restraint stresses on the central histaminergic neuron system of Fischer rat","volume":"262","author":"Ito","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0370","first-page":"611","article-title":"Possible contributory role of the central histaminergic system in the forced swimming model","volume":"42","author":"Noguchi","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tins.2014.12.008_bib0375","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1460-9568.2004.03540.x","article-title":"Decreased histamine H1 receptor binding in the brain of depressed patients","volume":"20","author":"Kano","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0380","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jad.2012.09.008","article-title":"Unaltered histaminergic system in depression: a postmortem study","volume":"146","author":"Shan","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tins.2014.12.008_bib0385","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0896-6273(04)00247-8","article-title":"Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior","volume":"42","author":"John","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2014.12.008_bib0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2014.12.008_bib0395","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2014.12.008_bib0400","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tins.2014.12.008_bib0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2014.12.008_bib0410","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.0073-14.2014","article-title":"Conditional ablation of orexin\/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function","volume":"34","author":"Tabuchi","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0415","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0306-4522(03)00238-0","article-title":"Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats","volume":"119","author":"Torrealba","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0420","doi-asserted-by":"crossref","first-page":"12437","DOI":"10.1523\/JNEUROSCI.0706-12.2012","article-title":"Optogenetic probing of fast glutamatergic transmission from hypocretin\/orexin to histamine neurons in situ","volume":"32","author":"Schone","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2014.12.008_bib0425","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1073\/pnas.181330998","article-title":"Arousal effect of orexin A depends on activation of the histaminergic system","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2014.12.008_bib0430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/sleep\/32.2.175","article-title":"Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls","volume":"32","author":"Nishino","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.tins.2014.12.008_bib0435","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.5665\/sleep.2114","article-title":"Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions","volume":"35","author":"Dauvilliers","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.tins.2014.12.008_bib0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/WNF.0b013e318246879d","article-title":"Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness","volume":"35","author":"Inocente","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0445","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2014.12.008_bib0450","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(01)02663-1","article-title":"Mice lacking histidine decarboxylase exhibit abnormal mast cells","volume":"502","author":"Ohtsu","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0460","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neubiorev.2014.03.009","article-title":"Modulation of behavior by the histaminergic system: Lessons from HR-and HR-deficient mice","volume":"42C","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tins.2014.12.008_bib0465","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5665\/sleep\/32.1.111","article-title":"A consensus definition of cataplexy in mouse models of narcolepsy","volume":"32","author":"Scammell","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.tins.2014.12.008_bib0470","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/1096-9861(20000925)425:3<422::AID-CNE7>3.0.CO;2-H","article-title":"Sex differences in the distribution of androgen receptors in the human hypothalamus","volume":"425","author":"Fernandez-Guasti","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tins.2014.12.008_bib0475","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/hup.430","article-title":"The effects of a sedative antihistamine, d-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET)","volume":"17","author":"Mochizuki","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tips.2006.03.008","article-title":"The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity","volume":"27","author":"Masaki","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tins.2014.12.008_bib0485","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1073\/pnas.93.23.13316","article-title":"Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors","volume":"93","author":"Inoue","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tins.2014.12.008_bib0490","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neures.2006.10.020","article-title":"Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors","volume":"57","author":"Dai","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0495","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-H","article-title":"Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates","volume":"526","author":"Martinez-Mir","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0500","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-5793(01)03070-8","article-title":"Histamine deficiency induces tissue-specific down-regulation of histamine H2 receptor expression in histidine decarboxylase knockout mice","volume":"508","author":"Fitzsimons","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0505","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2004.12.017","article-title":"The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation","volume":"132","author":"Jin","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0510","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00001756-200102120-00016","article-title":"Immunological identification of the mammalian H3 histamine receptor in the mouse brain","volume":"12","author":"Chazot","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2014.12.008_bib0515","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","article-title":"A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain","volume":"114","author":"Pillot","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2014.12.008_bib0520","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1248\/bpb.31.2163","article-title":"Histamine H3 receptor antagonists go to clinics","volume":"31","author":"Sander","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.tins.2014.12.008_bib0525","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/BF03354086","article-title":"Histamine H3 receptor inhibition of K(+)-evoked release of acetylcholine from rat cortex in vivo","volume":"45","author":"Blandina","year":"1996","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0530","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00180008","article-title":"H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase","volume":"350","author":"Schlicker","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0535","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.schres.2013.02.030","article-title":"Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia","volume":"146","author":"Egan","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2014.12.008_bib0540","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/bbrc.2001.4976","article-title":"Structure and expression of the human histamine H4-receptor gene","volume":"284","author":"Coge","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2014.12.008_bib0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1476-5381.2009.00227.x","article-title":"The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS","volume":"157","author":"Connelly","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0550","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00210-011-0700-4","article-title":"Commercially available antibodies against human and murine histamine H(4)-receptor lack specificity","volume":"385","author":"Beermann","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0555","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(87)90504-0","article-title":"Is neurotransmitter histamine predominantly inactivated in astrocytes?","volume":"80","author":"Rafalowska","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2014.12.008_bib0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/PL00005137","article-title":"Glial cells participate in histamine inactivation in vivo","volume":"357","author":"Huszti","year":"1998","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tins.2014.12.008_bib0565","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/sleep\/32.2.181","article-title":"CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome","volume":"32","author":"Kanbayashi","year":"2009","journal-title":"Sleep"}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223614002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223614002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T07:03:40Z","timestamp":1717657420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223614002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0166223614002367"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2014.12.008","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The human histaminergic system in neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}